Will OCEANIC-STROKE change your approach to secondary stroke prevention for high-risk TIA and non-cardioembolic stroke?

I would consider the OCEANIC-STROKE study a major contribution to the literature on secondary stroke prevention. The study included only noncardioembolic and nonlacunar strokes, with evidence of intracranial or general atherosclerosis (at least one of the above categories). It showed a significant b...

I would suggest that this question may need to wait until we have regulatory approvals and availability. However, the evidence from OCEANIC-STROKE is compelling. The trial hit it out of the park on all metrics. It looks like asundexian is a safe and effective adjuvant for stroke prevention. See comm...